Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0071 Transporter Info
Gene Name	ABCG1
Transporter Name	ATP-binding cassette sub-family G member 1
Gene ID	9619
UniProt ID	P45844

Post-Translational Modification of This DT
Overview of ABCG1 Modification Sites with Functional and Structural Information
Sequence	M A C L M A A F S V G T A M N A S S Y S A E M T E P K S V C V S V D E V V S S N M E A T E T D L L N G H L K K V D N N L T E A Q R F S S L P R R A A V N I E F R D L S Y S V P E G P W W R K K G Y K T L L K G I S G K F N S G E L V A I M G P S G A G K S T L M N I L A G Y R E T G M K G A V L I N G L P R D L R C F R K V S C Y I M Q D D M L L P H L T V Q E A M M V S A H L K L Q E K D E G R R E M V K E I L T A L G L L S C A N T R T G S L S G G Q R K R L A I A L E L V N N P P V M F F D E P T S G L D S A S C F Q V V S L M K G L A Q G G R S I I C T I H Q P S A K L F E L F D Q L Y V L S Q G Q C V Y R G K V C N L V P Y L R D L G L N C P T Y H N P A D F V M E V A S G E Y G D Q N S R L V R A V R E G M C D S D H K R D L G G D A E V N P F L W H R P S E E V K Q T K R L K G L R K D S S S M E G C H S F S A S C L T Q F C I L F K R T F L S I M R D S V L T H L R I T S H I G I G L L I G L L Y L G I G N E A K K V L S N S G F L F F S M L F L M F A A L M P T V L T F P L E M G V F L R E H L N Y W Y S L K A Y Y L A K T M A D V P F Q I M F P V A Y C S I V Y W M T S Q P S D A V R F V L F A A L G T M T S L V A Q S L G L L I G A A S T S L Q V A T F V G P V T A I P V L L F S G F F V S F D T I P T Y L Q W M S Y I S Y V R Y G F E G V I L S I Y G L D R E D L H C D I D E T C H F Q K S E A I L R E L D V E N A K L Y L D F I V L G I F F I S L R L I A Y F V L R Y K I R A E R
PTM type	X-Palmitoylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Palmitoylation
Cysteine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing the surface membrane expression of ABCG1			[1]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Cholesterol	Results for Drug	Decreasing efflux of cholesterol
Modified Residue	Cysteine	Modified Location	311
Modified State	Cysteine to Alanine/Serine mutation
Studied Phenotype	Atherosclerosis [ICD11: BD40]
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Palmitoylation at ABCG1 Cysteine 311 (i.e. Cysteine to Alanine/Serine mutation) have been reported to decrease its surface membrane expression.
PTM Phenomenon 2	No significant effect			[1]
Role of PTM	No Significant Effect
Affected Drug/Substrate	Cholesterol	Results for Drug	no effect in the transport function
Modified Residue	Cysteine	Modified Location	26
Modified State	Cysteine to Alanine/Serine mutation
Studied Phenotype	Atherosclerosis [ICD11: BD40]
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells; Mouse macrophage (J774) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Palmitoylation at ABCG1 Cysteine 26 (i.e. Cysteine to Alanine/Serine mutation) have been reported to have no significant alteration in its expression or activity.
PTM Phenomenon 3	No significant effect			[1]
Role of PTM	No Significant Effect
Affected Drug/Substrate	Cholesterol	Results for Drug	no effect in the transport function
Modified Residue	Cysteine	Modified Location	150
Modified State	Cysteine to Alanine/Serine mutation
Studied Phenotype	Atherosclerosis [ICD11: BD40]
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells; Mouse macrophage (J774) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Palmitoylation at ABCG1 Cysteine 150 (i.e. Cysteine to Alanine/Serine mutation) have been reported to have no significant alteration in its expression or activity.
PTM Phenomenon 4	No significant effect			[1]
Role of PTM	No Significant Effect
Affected Drug/Substrate	Cholesterol	Results for Drug	no effect in the transport function
Modified Residue	Cysteine	Modified Location	390
Modified State	Cysteine to Alanine/Serine mutation
Studied Phenotype	Atherosclerosis [ICD11: BD40]
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells; Mouse macrophage (J774) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Palmitoylation at ABCG1 Cysteine 390 (i.e. Cysteine to Alanine/Serine mutation) have been reported to have no significant alteration in its expression or activity.
PTM Phenomenon 5	No significant effect			[1]
Role of PTM	No Significant Effect
Affected Drug/Substrate	Cholesterol	Results for Drug	no effect in the transport function
Modified Residue	Cysteine	Modified Location	402
Modified State	Cysteine to Alanine/Serine mutation
Studied Phenotype	Atherosclerosis [ICD11: BD40]
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells; Mouse macrophage (J774) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Palmitoylation at ABCG1 Cysteine 402 (i.e. Cysteine to Alanine/Serine mutation) have been reported to have no significant alteration in its expression or activity.
Phosphorylation
Serine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 32 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	67
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 67 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	68
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 68 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCG1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	83
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 83 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCG1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	85
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 85 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCG1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	105
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 105 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCG1			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	110
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 110 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCG1			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	120
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 120 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCG1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	125
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 125 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCG1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	420
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 420 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCG1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	494
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Serine 494 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	99
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Threonine 99 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Threonine 137 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	412
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Threonine 412 has the potential to affect its expression or activity.
Tyrosine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Tyrosine 84 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	667
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Tyrosine 667 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	672
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCG1 Tyrosine 672 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	30
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCG1 Cystine 30 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	154
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCG1 Cystine 154 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	315
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCG1 Cystine 315 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCG1			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	394
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCG1 Cystine 394 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCG1			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	406
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCG1 Cystine 406 has the potential to affect its expression or activity.
Ubiquitination
Arginine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	65
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Arginine 65 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	80
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Arginine 80 has the potential to affect its expression or activity.
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	76
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Asparagine 76 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	109
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Asparagine 109 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	356
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Asparticacid 356 has the potential to affect its expression or activity.
Glutamicacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[13]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	191
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Glutamicacid 191 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	332
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Glutamicacid 332 has the potential to affect its expression or activity.
Glycine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	51
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Glycine 51 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	118
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Glycine 118 has the potential to affect its expression or activity.
Isoleucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	104
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Isoleucine 104 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[13]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	200
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Isoleucine 200 has the potential to affect its expression or activity.
Leucine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	100
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Leucine 100 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	113
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Leucine 113 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[13]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	186
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Leucine 186 has the potential to affect its expression or activity.
Lysine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 54 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	95
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 95 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	98
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 98 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	102
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 102 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	107
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 107 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCG1			[13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	189
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 189 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 354 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	376
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Lysine 376 has the potential to affect its expression or activity.
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[13]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	167
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Methionine 167 has the potential to affect its expression or activity.
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	365
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Proline 365 has the potential to affect its expression or activity.
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Serine 32 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	85
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Serine 85 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	351
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Serine 351 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	99
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Threonine 99 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCG1			[12]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	56
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 Valine 56 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Accelerating ABCG1 degradation			[14]
Role of PTM	Degradation via Proteosome
Experimental Material(s)	Chinese hamster ovary (CHO) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCG1 have been reported to accelerate its degradation, thereby affecting its expression or activity.

References
1	Characterization of palmitoylation of ATP binding cassette transporter G1: effect on protein trafficking and function. Biochim Biophys Acta. 2013 Jun;1831(6):1067-78.
2	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
3	Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis. Oncotarget. 2017 Oct 25;8(61):102898-102911.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
6	Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation. Clin Proteomics. 2013 Jan 3;10(1):1.
7	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
8	Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics. 2012 Dec;11(12):1741-57.
9	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
10	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCG1_HUMAN)
11	Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability. Mol Cell Proteomics. 2017 Sep;16(9):1694-1704.
12	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
13	Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Mol Cell Proteomics. 2012 May;11(5):148-59.
14	Cellular cholesterol regulates ubiquitination and degradation of the cholesterol export proteins ABCA1 and ABCG1. J Biol Chem. 2014 Mar 14;289(11):7524-36.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence